Joint meeting with Neurodegenerative Diseases: Genes, Mechanisms and Therapeutics
June 7-9, 2021 | 9:00AM EDT | 1:00PM UTC | 3:00PM CEST*
*Program is in development and subject to change
The emerging field of neuroimmunology is one of the most exciting and fastest moving areas in biomedical research. Communication between the brain and the immune system play critical roles in neural development, homeostasis and disease. Emerging human genetics implicate innate and adaptive immune pathways in many neurological diseases; however, the disease mechanisms remain elusive. Intersections between the nervous and immune systems are complex and can have both beneficial and detrimental impact on brain function depending on the context. It is thus crucial that we understand the mechanisms that give rise to these divergent outcomes. The extraordinary depth and breadth of science is emphasized by the program and includes topics such as peripheral immunity, inflammation, and interactions between the brain and the periphery, microglia function and dysfunction, microbiome and gut-brain axis, immune mechanisms of synapse loss in development and disease, mechanisms of neuroimmune communication at brain borders, and glymphatic-lymphatic connections. The program will also include several workshops on new discoveries, tools and approaches to analyze and integrate big-data (omics) aspects of neuroimmunology research, and to model neural-immune signaling in different contexts, including human disease.
This conference will bring together an interdisciplinary group of scientists to discuss these and other emerging topics in neuroimmunology, with emphasis on the mechanisms underlying neural-immune crosstalk in health and disease. A major goal is to cultivate cross-disciplinary research by bringing together cutting-edge researchers that represent the entire spectrum of the field, from pure neuroscience to pure immunology, with the emerging field of neuroimmunology in between them. The conference will also provide opportunities for outstanding senior leaders to inspire young scientists in the field to move in innovative directions.
Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD
Abstract Submission
‣ For Short Talk Consideration: April 26, 2021
‣ For ePoster Presentation: May 24, 2021
Final ePoster / SciTalk Submission: May 27, 2021
Financial Aid Application: May 24, 2021
*Abstract submission is required in order to submit an ePoster and/or Scitalk
#VKSNeuroImmune21
Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine-related fields, are eligible to apply for a FREE registration code.
Find out more about financial aid opportunities here!
Showcase your work to global audiences on the eSymposia platform!
Submit your abstract by the Short Talk Deadline for the opportunity to be selected for a short talk presentation alongside field leaders on the meeting program!
ePoster presenters will be provided with their own dedicated abstract listing on the event website to display their work in multiple formats, and interact with meeting participants. ePoster features include:
To submit your work for an ePoster presentation, and to be considered for short talk selection, go to the “Submit an Abstract” tab on the event homepage.
Christopher K. Glass, MD, PhD
University of California, San Diego
Akiko Iwasaki, PhD
HHMI/Yale University School of Medicine
Burkhard Becher
University of Zurich, Switzerland
Gloria Choi
Massachusetts Institute of Technology, USA
Marco Colonna
Washington University School of Medicine, USA
Richard Daneman
University of California, San Diego, USA
Betty Diamond
Feinstein Institute for Medical Research, USA
Anthony J. Filiano
Duke University, USA
Sonia Garel
INSERM, France
Christopher K. Glass
University of California, San Diego, USA
Jonathan P. Godbout
Ohio State University, USA
David M. Holtzman
Washington University, USA
Elaine Y. Hsiao
University of California, Los Angeles, USA
Akiko Iwasaki
HHMI/Yale University School of Medicine, USA
Brian Kim
Washington University School of Medicine, USA
Jonathan Kipnis
Washington University School of Medicine, USA
Holly Kordasiewicz
Ionis Pharmaceuticals, USA
Maria Lehtinen
Harvard Medical School, USA
Joseph W. Lewcock
Denali Therapeutics, USA
Shane Antony Liddelow
New York University Langone Medical Center, USA
Daniel Mucida
Rockefeller University, USA
Maiken Nedergaard
University of Rochester, USA
Francisco J. Quintana
Harvard Medical School, USA
Dorothy Schafer
University of Massachusetts Medical School, USA
Michal Schwartz
Weizmann Institute of Science, Israel
Beth Stevens
Boston Children's Hospital, Harvard Medical School, USA
Henrique Veiga-Fernandes
Champalimaud Research, Portugal
Frauke Zipp
Johannes-Gutenberg-Universität Mainz, Germany
The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.
This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.